We specialise in full-service custom research and consultancy for global healthcare. We use the full range of qualitative and quantitative techniques to undertake both ad hoc and tracking studies across a range of therapy areas and territories
Within prescription medicines, we have therapeutic specialists and experience in a broad range of therapy areas from chronic illnesses to rare diseases.
Consumer health and nutritionals
We combine our knowledge of the pharmaceutical sector with our understanding of patients and consumers to deliver integrated insights.
Medical devices and diagnostics
Our experience covers everything from insulin pens to large-scale surgical console systems. We use our knowledge of the unique market dynamics and regulatory nature of this sector to improve client understanding.
- Some example case studiesShifting perceptions of the use of probiotics in IBS Management
The challengeOur client was planning to launch an over-the-counter (OTC) probiotics product for the purposes of improving IBS management and wanted to understand current perceptions, practices and usage amoungst a range of healthcare professionals in emerging markets. They wanted to uncover potential leverage points to build a strong storyline and communication strategy for their product, which would encourage healthcare professionals to recommend its use to…read more »Understanding the patient journey and addiction treatment pathways
The challengeOur client had previously conducted some research and knew that a large proportion of target patients also had addiction issues. They wanted to know more about addiction treatment pathways and the issues that this large proportion of their customers and potential HCP treaters were facing. Therefore, they were seeking further insights to gain a 360 degree understanding to better serve their customers needs. …read more »Qualitative research with payers in low and middle income countries
The challenge Our client wanted to understand in detail the usage decision drivers, triggers and processes for a high-cost innovative Acute Heart Failure (AHF) drug used in the acute emergency setting in low and middle income countries where patients self-pay for healthcare. They also wanted to obtain a deep understanding of the groups of patients for whom self-pay is an issue and the sources of…read more »
- Our latest white papersUnderstanding the chronic disease patient journey in emerging markets
In this paper, we explore the chronic disease patient journey in emerging markets and provide you with the insights you require to identify the key inflection points in these rapidly changing and diverse regions.read more »US Presidential Election: The legacy of the Affordable Care Act and the future for healthcare
Our latest Free Thinking white paper explores the legacy of the Affordable Care Act and the future for healthcareread more »Are biosimilars the answer to the rising cost of RA treatment?
Our latest Free Thinking white paper explores why the uptake of Biosimilars has been slower than expected and asks what's next for RA?read more »